Mike Cusnir MD
Complementary and Integrative
Medical Director Mount Sinai Comprehensive Cancer Center Division Chief Hematology and Oncology Mount Sinai Comprehensive Cancer Center Miami Beach Florida
Join to View Full Profile
4306 Alton Rd3rd FloorMiami Beach, FL 33140
Phone+1 305-535-3337
Fax+1 305-535-3324
Dr. Cusnir is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Mike Cusnir, MD is a Miami-based Oncologist specializing in Gastrointestinal Oncology as well as Complementary and Integrative care. With fellowships in Integrative Medicine from the University of Arizona College of Medicine-Tucson and Hematology and Medical Oncology from the University of Maryland. Dr. Cusnir's research is well-published, particularly on the topic of GI Oncology. He has served as a Principal Investigator and Contact in numerous clinical trials and received awards such as the CMS Meaningful Use Stage 1 Certification and recognition as a Top Doctor in South Florida.
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Integrative Medicine, 2010 - 2012
University of MarylandFellowship, Hematology and Medical Oncology, 2000 - 2003
Maimonides Medical CenterResidency, Internal Medicine, 1997 - 2000
Pontifical Xavierian UniversityClass of 1994
Certifications & Licensure
FL State Medical License 2003 - 2027
MD State Medical License 2001 - 2004
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
- Gemcitabine Plus Cisplatin With or Without Bintrafusp Alfa (M7824) in Participants With 1L BTC Start of enrollment: 2019 Sep 20
- A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer Start of enrollment: 2018 Jun 19
Roles: Contact
Publications & Presentations
PubMed
- 13 citationsLong-Term Efficacy and Safety of Lifileucel Tumor-Infiltrating Lymphocyte Cell Therapy in Patients With Advanced Melanoma: A 5-Year Analysis of the C-144-01 Study.Theresa Medina, Jason A Chesney, Harriet M Kluger, Omid Hamid, Eric D Whitman
Journal of Clinical Oncology. 2025-11-20 - 73 citationsManagement of Locally Advanced Rectal Cancer: ASCO Guideline.Aaron J Scott, Erin B Kennedy, Jordan Berlin, Gina Brown, Myriam Chalabi
Journal of Clinical Oncology. 2024-10-01 - How best to extend overall survival in metastatic colorectal cancer: Q&A.Tanios S Bekaii-Saab, Afsaneh Barzi, Mike Cusnir
Clinical Advances in Hematology & Oncology. 2024-06-01
Press Mentions
Dr. Cusnir on the Role of Ramucirumab in Gastric CancerFebruary 5th, 2020- Novel Agents and Strategies Propelling Progress in Gastric CancerJanuary 3rd, 2020
Immunotherapy Is Giving Some Cancer Patients a New Life When They Had All but Given up | Miami HeraldMay 25th, 2018
Professional Memberships
- Member
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
